In the study by Joffe et al. cardiac arrest patients did not receive P2Y12 inhibitors and had a much higher incidence of stent thrombosis (10.9%) than patients in the control group (2.0%), who were treated with P2Y12 inhibitors but had not had previous cardiac arrests. The gene discussed is P2RY12; the disease is cardiac arrest.